dockets: FDA-2009-P-0597

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
FDA-2009-P-0597 FDA Specific Legal and Scientific Requirements be Upheld in the Review of Proposed Generic Copies of Inhalation Products Containing Fluticasone Propionate and/or Salmeterol Xinafoate Nonrulemaking 2022-01-05T01:04:00Z 0b00006480a6c5c2   Status: OPEN     ["fluticasone", "salmeterol xinafoate", "propionate", "inhalation", "asthma", "flovent", "diskus", "CDER"] CDER Specific Legal and Scientific Requirements be Upheld in the Review of Proposed Generic Copies of Inhalation Products Containing Fluticasone Propionate and/or Salmeterol Xinafoate     {"displayProperties": [{"name": "abstract", "label": "General Information", "tooltip": "Describes an agency's specific regulatory action; equivalents: Abstract, Description, Docket Subject, Related To, Summary."}, {"name": "generic", "label": "Docket Item Code", "tooltip": "An agency specific code that identifies the type of document that established the docket (regulatory action)."}, {"name": "program", "label": "Center", "tooltip": "The agency specific program associated with the docket (regulatory action); equivalents: Docket Item Code, Location."}, {"name": "field2", "label": "Docket Status", "tooltip": "Used to Identity that a Docket's Status is Open or Closed"}, {"name": "shortTitle", "label": "Short Title", "tooltip": "A combination of letters and or numbers assigned to an agency's regulatory action for purposes of brevity."}], "keywords": ["fluticasone", "salmeterol xinafoate", "propionate", "inhalation", "asthma", "flovent", "diskus", "CDER"], "modifyDate": "2022-01-05T01:04:00Z", "dkAbstract": "Status: OPEN", "agencyId": "FDA", "program": "CDER", "shortTitle": "Specific Legal and Scientific Requirements be Upheld in the Review of Proposed Generic Copies of Inhalation Products Containing Fluticasone Propionate and/or Salmeterol Xinafoate", "subType2": null, "title": "Specific Legal and Scientific Requirements be Upheld in the Review of Proposed Generic Copies of Inhalation Products Containing Fluticasone Propionate and/or Salmeterol Xinafoate", "generic": "P", "field1": null, "docketType": "Nonrulemaking", "petitionNbr": null, "rin": null, "organization": null, "legacyId": null, "subType": null, "category": null, "field2": "open", "effectiveDate": null, "objectId": "0b00006480a6c5c2"} single_get

Links from other tables